Category: Pharmaceuticals
Pharmaceuticals market research reports by DelveInsight
-
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2025
“Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor ... Read More
-
Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2025
“Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Ubiquitin Specific Proteases (USP) Inhibitor development. The report provides detailed co ... Read More
-
Androgen receptor antagonists - Pipeline Insight, 2025
DelveInsight’s, “Androgen receptor antagonists - Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Androgen receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025
“Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Recepto ... Read More
-
Selectin Inhibitor - Pipeline Insight, 2025
“Selectin Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Selectin Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025
“Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor development. The report ... Read More
-
Chronic inflammatory demyelinating polyneuropathy (CIDP)- Pipeline Insight, 2025
DelveInsight’s, “Chronic inflammatory demyelinating polyneuropathy (CIDP)- Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 4+ pipeline drugs in Chronic inflammatory demyelinating polyneuropathy (CIDP)pipeline landscape. It covers the pipeline drug profiles, incl ... Read More
-
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025
DelveInsight’s, “Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Guillain-Barré Syndrome (GBS) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It al ... Read More
-
Postmenopausal Osteoporosis - Pipeline Insight, 2025
DelveInsight’s, “Postmenopausal Osteoporosis - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Postmenopausal Osteoporosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ... Read More
-
Glioma - Pipeline Insight, 2025
DelveInsight’s, “Glioma - Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by ... Read More
-
5-Alpha Reductase Inhibitor - Pipeline Insight, 2025
“5-Alpha Reductase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-Alpha Reductase Inhibitor development. The report provides detailed coverage of the pipeline landscape f ... Read More
-
5-HT1A Antagonist - Pipeline Insight, 2025
“5-HT1A Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1A Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
5-HT1D Agonist - Pipeline Insight, 2025
DelveInsight’s, “5-HT1D Agonist - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in 5-HT1D Agonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ass ... Read More
-
5-HT2B Antagonist - Pipeline Insight, 2025
“5-HT2B Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2B Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
5-HT6 Antagonist - Pipeline Insight, 2025
“5-HT6 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT6 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
5-HT2C Antagonist - Pipeline Insight, 2025
“5-HT2C Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2C Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
Adenosine A2A Receptor Agonist - Pipeline Insight, 2025
“Adenosine A2A Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2A Receptor Agonist development. The report provides detailed coverage of the pipeline lands ... Read More
-
Adrenergic Antagonist - Pipeline Insight, 2025
“Adrenergic Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adrenergic Antagonist development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More
-
Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025
“Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist development. The rep ... Read More
-
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025
“Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- development. The report provides detailed coverage ... Read More
-
Androgen Agonist - Pipeline Insight, 2025
“Androgen Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Androgen Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025
“Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator development. The repor ... Read More
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2025
“Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor development. The repor ... Read More
-
ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor - Pipeline Insight, 2025
“ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across ATP Binding Cassette Sub Family B member 1 (ABC ... Read More
-
Autophagy modulators - Pipeline Insight, 2025
“Autophagy modulators - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Autophagy modulators development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More
Research Assistance
